<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Baseline characteristics of patients undergoing chemotherapy for hematological malignancies.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <tbody>
   <tr>
    <td>
     <bold>Male gender</bold>, n(%)
    </td>
    <td>233 (55.5%)</td>
   </tr>
   <tr>
    <td>
     <bold>Race</bold>, n(%)
    </td>
    <td/>
   </tr>
   <tr>
    <td>Caucasian</td>
    <td>398 (94.8%)</td>
   </tr>
   <tr>
    <td>Asian</td>
    <td>10 (2.4%)</td>
   </tr>
   <tr>
    <td>Hispanic</td>
    <td>8 (1.9%)</td>
   </tr>
   <tr>
    <td>African</td>
    <td>4 (1%)</td>
   </tr>
   <tr>
    <td>
     <bold>Age</bold>, mean ± SD
    </td>
    <td>63 ± 16</td>
   </tr>
   <tr>
    <td>
     <bold>Most common hematological malignancy</bold>, n(%)
    </td>
    <td/>
   </tr>
   <tr>
    <td>Diffuse large B cell lymphoma</td>
    <td>72 (17.1%)</td>
   </tr>
   <tr>
    <td>Multiple mieloma</td>
    <td>65 (15.5%)</td>
   </tr>
   <tr>
    <td>Follicular lymphoma</td>
    <td>57 (13.6%)</td>
   </tr>
   <tr>
    <td>Acute leukemia</td>
    <td>41 (9.8%)</td>
   </tr>
   <tr>
    <td>Chronic myeloid leukemia</td>
    <td>37 (8.8%)</td>
   </tr>
   <tr>
    <td>Hodgkin lymphoma</td>
    <td>22 (5.2%)</td>
   </tr>
   <tr>
    <td>Myelodysplastic syndrome</td>
    <td>22 (5.2%)</td>
   </tr>
   <tr>
    <td>Chronic lymphocytic leukemia</td>
    <td>18 (4.3%)</td>
   </tr>
   <tr>
    <td>
     <bold>Anti-CD20-containing regimens</bold>, n(%)
    </td>
    <td>166 (39.5%)</td>
   </tr>
   <tr>
    <td>
     <bold>Tyrosine-kinase inhibitors</bold>, n(%)
    </td>
    <td>64 (15.2%)</td>
   </tr>
   <tr>
    <td>
     <bold>HIV infection</bold>, n(%)
    </td>
    <td>4 (1%)</td>
   </tr>
   <tr>
    <td>
     <bold>Previously known viral hepatitis</bold>, n(%)
    </td>
    <td>18 (4.3%)*</td>
   </tr>
   <tr>
    <td>Anti-HCV positive</td>
    <td>10</td>
   </tr>
   <tr>
    <td>HBsAg positive</td>
    <td>1</td>
   </tr>
   <tr>
    <td>Anti-HBc positive</td>
    <td>11</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>*4 patients were both anti-HCV and anti-HBc positive.</p>
  <p>There were no missing data for any of the variables.</p>
 </table-wrap-foot>
</table-wrap>
